MarketInOut Stock Screener Log In | Sign Up

Genscript Biotech Corp

HKSE • Healthcare • Biotechnology • Quote as of 10/28/2026 14:59
Genscript Biotech Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization75,256 mln
Float885 mln
Earnings Date03/24/2027

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.3
Reliable

1-Year Forecast

32.94
Limited downside

Relative Strength

86 / 100
Strongly outperforming

Debt / Equity

0.09
Debt-free

Pre-Tax Margin

-36%
Deeply loss-making

Business Description

Founded in 2002 and headquartered in Hong Kong, Genscript Biotech Corporation is a global life sciences company that supports researchers, biotech firms, and pharmaceutical companies with a broad range of tools and services. The company helps accelerate the development of new medicines, including therapeutic antibodies and gene and cell therapies, while also producing industrial enzymes for commercial use. Genscript serves customers across North America, Europe, China, and the Asia Pacific region through three main business areas covering research products, drug development support, and biotechnology-driven industrial manufacturing.

Key Fundamentals

EPS-2.29
ROE-8.65
RPS3.03
ROIC2.29
ROA-7.03
Interest Cover7.19
EBITDA, mln-1,666
EV / EBITDA-58.44
EV / EBIT-42.56
Revenue, mln6,600
EV / Revenue14.75

Quote Details

Last 36.44
Change 3.44 (10.42%)
Open 36.08
Volume 56,848,080
Turnover 2,071,543,936
Average Volume 42,807,648

Financial Ratios

Pre-Tax Profit Margin-36
Leverage Ratio1.23
Current Ratio1.49
Price / Book3.16
Price / Tangible Book3.17
Price / Cash Flow61.46
Price / Free Cash Flow183
Debt / Equity0.09
Price / Sales14.77

Financial Strength

Altman Z-Score9.52
Piotroski F-Score 6 / 9
Beneish M-Score-3.3
Price to Intrinsic Value15.96
1-Year Target Price32.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.18% 91 / 100   
1 Month -15.14% 24 / 100   
2 Months 133% 99 / 100   
6 Months 168% 98 / 100   
1 Year 132% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog